Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02703948 · ClinicalTrials.gov registry record · NA
Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation
A NA study of Lip Augmentation and Correction of Perioral Rhytids, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 4
- Study locations
NCT02703948 is a NA study of Lip Augmentation and Correction of Perioral Rhytids that has completed, run by Galderma R&D. The registered enrollment target is 60 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT02703948, a NA study of Lip Augmentation and Correction of Perioral Rhytids, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a multi-center, open-label, single-arm study to assess the safety of an injection technique with Restylane Silk in lip augmentation and correction of perioral rhytids .
Conditions Studied
Interventions
- DEVICE Restylane Silk with Lidocaine
Study Locations (4)
California
- United States, California - Beverly Hills
- United States, California - San Diego
Florida
- United States, Florida - Miami
Georgia
- United States, Georgia - Roswell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02703948
The ClinicalTrials.gov registry entry for NCT02703948 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lip Augmentation and Correction of Perioral Rhytids appearing as the primary indexed condition, and to 1 intervention - of which Restylane Silk with Lidocaine is the first listed.
NCT02703948 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT02703948 about?
NCT02703948 is a clinical study titled "Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation". This is a multi-center, open-label, single-arm study to assess the safety of an injection technique with Restylane Silk in lip augmentation and correction of perioral rhytids .
What is the current status of trial NCT02703948?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-03. Estimated completion is 2016-08.
What conditions does trial NCT02703948 study?
This clinical trial studies the following conditions: Lip Augmentation and Correction of Perioral Rhytids.
What interventions are being tested in trial NCT02703948?
The interventions under investigation include: Restylane Silk with Lidocaine (DEVICE).
Who is sponsoring clinical trial NCT02703948?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02703948 being conducted?
This trial has 4 study locations across California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.